Literature DB >> 6106210

[On the manufacture and testing of butaperazine matrix tablets with silicone varnish NH 30 as a structural substance (author's transl)].

H Kala, D Wendorff, H Moldenhauer.   

Abstract

It is reported of the manufacture and testing of matrix tablets containing butaperazine dihydrogen maleinate as a model substance and silicone varnish NH 30 as a structural constituent. On in vitro testing in artificial gstric juice (pH = 1.2), The drug was fully available when the tablets had been prepared by the method of separate granulation. Furthermore, the release of the drug was studied by means of the half-change method at different pH values, in artificial intestinal juice (pH = 7.5) and under sink conditions. The last-mentioned method is concerned with the drug transferred in vitro. Variations in pressing pressure and varnish concentration permit to prepare tablets of planned release characteristics. The release rates were higher in systems with n-heptane as the lipophil phase than in systems under non-sink conditions. This method is sensitive enough to differentiate among batches of tablets varying in drug release.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6106210

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  1 in total

Review 1.  Oral controlled release dosage forms. A review.

Authors:  P De Haan; C F Lerk
Journal:  Pharm Weekbl Sci       Date:  1984-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.